BR112013025157A2 - composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável - Google Patents

composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável

Info

Publication number
BR112013025157A2
BR112013025157A2 BR112013025157A BR112013025157A BR112013025157A2 BR 112013025157 A2 BR112013025157 A2 BR 112013025157A2 BR 112013025157 A BR112013025157 A BR 112013025157A BR 112013025157 A BR112013025157 A BR 112013025157A BR 112013025157 A2 BR112013025157 A2 BR 112013025157A2
Authority
BR
Brazil
Prior art keywords
bioabsorbable
filler
based material
compositions
biodegradable
Prior art date
Application number
BR112013025157A
Other languages
English (en)
Portuguese (pt)
Inventor
Karlsson Anders
Eloy Rosy
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BR112013025157A2 publication Critical patent/BR112013025157A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
BR112013025157A 2011-03-31 2012-04-02 composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável BR112013025157A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161470211P 2011-03-31 2011-03-31
PCT/EP2012/055979 WO2012131095A1 (en) 2011-03-31 2012-04-02 Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material

Publications (1)

Publication Number Publication Date
BR112013025157A2 true BR112013025157A2 (pt) 2019-09-24

Family

ID=45953116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025157A BR112013025157A2 (pt) 2011-03-31 2012-04-02 composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável

Country Status (6)

Country Link
US (1) US20140065221A1 (enExample)
EP (1) EP2691115A1 (enExample)
JP (1) JP2014510590A (enExample)
BR (1) BR112013025157A2 (enExample)
CA (1) CA2830654A1 (enExample)
WO (1) WO2012131095A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010246067B2 (en) 2009-05-04 2016-07-07 Eyepoint Pharmaceuticals Us, Inc. Porous silicon drug-eluting particles
CN104586742A (zh) 2010-11-01 2015-05-06 普西维达公司 用于递送治疗剂的可生物侵蚀的硅基装置
CN105025928A (zh) 2013-03-15 2015-11-04 普西维达公司 用于递送治疗剂的可生物蚀解的硅基组合物
KR101647182B1 (ko) * 2014-02-10 2016-08-23 박용호 피부조직 복원용 필러엑스(Filler X) 조성물
US11389563B2 (en) 2017-06-12 2022-07-19 Advanced Aesthetic Technologies, Inc. Dermal filler
KR20210034544A (ko) 2018-05-09 2021-03-30 더 존스 홉킨스 유니버시티 향상된 연조직 대체 및 재생을 위한 나노섬유-하이드로겔 복합재료
JP2021522938A (ja) 2018-05-09 2021-09-02 ザ ジョンズ ホプキンス ユニバーシティ 細胞及び組織の送達のためのナノファイバー−ハイドロゲル複合体
CN114007662B (zh) * 2019-06-21 2023-02-28 高丽大学校产学协力团 维持体内体积的药剂、包括其的注射剂及其制备方法
KR102264957B1 (ko) * 2019-06-21 2021-06-17 고려대학교 산학협력단 체내 부피 유지 제제 및 이의 제조방법
JP2025041170A (ja) * 2023-09-13 2025-03-26 昌毅 本田 肛門狭窄化治療法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777041A (en) * 1986-08-07 1988-10-11 Charles Of The Ritz Group Ltd. Wrinkle treatment formulation
US5204382A (en) * 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
US5599852A (en) * 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
KR20010082721A (ko) * 2000-02-18 2001-08-30 고니시 진우에몬 지방산 함유 조성물
US20040047892A1 (en) * 2000-11-15 2004-03-11 Desrosiers Eric Andre Filler composition for soft tissue augmentation and reconstructive surgery
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
US9889151B2 (en) * 2007-10-15 2018-02-13 Hs Pharmaceuticals, Llc Silicate containing compositions and methods of treatment
DE102008033327A1 (de) * 2008-07-16 2010-01-21 Bayer Innovation Gmbh Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie

Also Published As

Publication number Publication date
CA2830654A1 (en) 2012-10-04
JP2014510590A (ja) 2014-05-01
WO2012131095A1 (en) 2012-10-04
EP2691115A1 (en) 2014-02-05
US20140065221A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
BR112013025157A2 (pt) composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
BRPI0907438A2 (pt) Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
BR112014001050A2 (pt) copolímero em bloco de poliéster poliamida, método para a preparação do mesmo, composição, produtos de liberação controlada e de cuidado pessoal, e, método para preparação de uma composição de gel
BRPI0908092A8 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BR112012030699A2 (pt) métodos para tratar câncer de bexiga
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
CU20140141A7 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas
PH12012501755A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
CO6420355A2 (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
BR112012005319A2 (pt) método para produzir uma resina sequestrante de oxigênio, composição e método para produzir um artigo
SG10201901713RA (en) Extracellular matrix compositions
BR112012020628A2 (pt) fotoiniciador de éter polialquílico, uso de um fotoiniciador de éter polialquílico, método para curar uma composição de matriz, e, composição de matriz
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
BRPI0906466A2 (pt) Composição para cuidado oral, e, métodos para preparar uma composição oral, e para aplicar uma quantidade eficaz da composição oral
BRPI0922924A2 (pt) composições para melhoria da saúde oral, método de uso de uma composição e uso de pelo menos uma bactéria benéfica para a preparação de uma composição para melhoria da saúde oral
BR112015014367A2 (pt) formulações inibidoras de lfa-1
PH12015502405A1 (en) Methods and compositions for wound healing
CL2011002965A1 (es) Compuestos derivados de piperidinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso de dichos compuestos para el tratamiento y/o profilaxis de trastornos cardiovasculares, tromboembolicos y/o tumores.
WO2013059233A3 (en) Thermoresponsive compositions for dermatological use and methods thereof
MX2011009277A (es) Composicion de leucocito activada.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.